Expert Review of Anticancer Therapy, Volume 18, Issue 3 (2018)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Review of Anticancer Therapy, Volume 18, Issue 3 (2018)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Volume 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
Prophylactic mastectomy for BRCA mutation carriers after ovarian cancer treatment: is it beneficial?
Joanne Kotsopoulos & Steven A. Narod
Pages: 199-200
Published online: 08 Jan 2018
CitationforProphylactic mastectomy for BRCA mutation carriers after ovarian cancer treatment: is it beneficial? | Full Text | References | PDF (251.9 KB)
  • 2705 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Drug Profile

Article
Ribociclib for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
Howard A. Burris III
Pages: 201-213
Published online: 19 Feb 2018
AbstractforRibociclib for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer | Full Text | References | PDF (1.5 MB)
  • 600 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Nivolumab for the treatment of urothelial cancers
Min Yuen Teo & Jonathan E. Rosenberg
Pages: 215-221
Published online: 31 Jan 2018
AbstractforNivolumab for the treatment of urothelial cancers | Full Text | References | PDF (693.1 KB)
  • 454 Views
  • 15 CrossRef citations
  • 0Altmetric

Review

Review
Current approaches for identifying high-risk non-muscle invasive bladder cancer
Oner Sanli & Yair Lotan
Pages: 223-235
Published online: 31 Jan 2018
AbstractforCurrent approaches for identifying high-risk non-muscle invasive bladder cancer | Full Text | References | PDF (1 MB)
  • 279 Views
  • 6 CrossRef citations
  • 0Altmetric
Review
Indications, complications, and outcomes following surgical management of locally advanced and metastatic renal cell carcinoma
Javier González, Jeffrey J. Gaynor, Mahmoud Alameddine, Manuel Esteban & Gaetano Ciancio
Pages: 237-250
Published online: 25 Jan 2018
AbstractforIndications, complications, and outcomes following surgical management of locally advanced and metastatic renal cell carcinoma | Full Text | References | PDF (1 MB)
  • 188 Views
  • 8 CrossRef citations
  • 0Altmetric
Review
The role of tumor angiogenesis as a therapeutic target in colorectal cancer
Francesca Battaglin, Alberto Puccini, Rossana Intini, Marta Schirripa, Alessandra Ferro, Francesca Bergamo, Sara Lonardi, Vittorina Zagonel, Heinz-Josef Lenz & Fotios Loupakis
Pages: 251-266
Published online: 19 Jan 2018
AbstractforThe role of tumor angiogenesis as a therapeutic target in colorectal cancer | Full Text | References | PDF (1.5 MB) | Supplemental
  • 736 Views
  • 34 CrossRef citations
  • 0Altmetric
Review
Combined therapy with epidermal growth factor receptor tyrosine kinase inhibitors for non–small cell lung cancer
Eiji Iwama, Yoichi Nakanishi & Isamu Okamoto
Pages: 267-276
Published online: 27 Jan 2018
AbstractforCombined therapy with epidermal growth factor receptor tyrosine kinase inhibitors for non–small cell lung cancer | Full Text | References | PDF (1.1 MB)
  • 295 Views
  • 11 CrossRef citations
  • 0Altmetric
Review
Clinical challenges in de novo pediatric acute myeloid leukemia
Kim Klein, Valérie de Haas & Gertjan J. L. Kaspers
Pages: 277-293
Published online: 20 Jan 2018
AbstractforClinical challenges in de novo pediatric acute myeloid leukemia | Full Text | References | PDF (1.3 MB)
  • 660 Views
  • 25 CrossRef citations
  • 0Altmetric
Review
A look at the progress of treating pancreatic cancer over the past 20 years
Ruediger Goess & Helmut Friess
Pages: 295-304
Published online: 16 Jan 2018
AbstractforA look at the progress of treating pancreatic cancer over the past 20 years | Full Text | References | PDF (931.2 KB)
  • 496 Views
  • 16 CrossRef citations
  • 0Altmetric

Corrigendum

Correction
Corrigendum
Page: 1
Published online: 10 Jan 2018
CitationforCorrigendum | Full Text | PDF (102.5 KB)
  • 368 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Multidisciplinary systemic and local therapies for metastatic renal cell carcinoma: a narrative review
Martin Zarba et al.
Review Article | Published online: 30 May 2024
First-line concomitant EGFR-TKI + chemotherapy versus EGFR-TKI alone for advanced EGFR-mutated NSCLC: a meta-analysis of randomized phase III trials
Thierry Landre et al.
Review Article | Published online: 30 May 2024
Bispecific antibodies in the treatment of Relapsed/Refractory large B-cell lymphoma
Gulrayz Ahmed et al.
Review Article | Published online: 29 May 2024
Antibody-drug conjugates, bispecific antibodies and CAR-T cells therapy in multiple myeloma
Paola Tacchetti et al.
Review Article | Published online: 26 May 2024
View all latest articles